In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies

被引:37
作者
Toulon, P. [1 ,2 ]
Eloit, Y. [2 ]
Smahi, M. [3 ]
Sigaud, C. [2 ]
Jambou, D. [2 ]
Fischer, F. [2 ]
Appert-Flory, A. [2 ]
机构
[1] Univ Nice Sophia Antipolis, Fac Med, Hematol Lab, Nice, France
[2] Hop Louis Pasteur, CHU, Serv Hematol Biol, Nice, France
[3] Hop Simone Veil, Hematol Lab, Eaubonne Montmorency, France
关键词
Factor deficiency; sensitivity; responsiveness; activated partial thromboplastin time; reagents; APTT REAGENTS; PROTHROMBIN TIME; FACTOR-VIII; FACTOR-IX; ACTIN FS; DIAGNOSIS; PHOSPHOLIPIDS; VARIABILITY; UPDATE; ASSAYS;
D O I
10.1111/ijlh.12499
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Activated partial thromboplastin time (aPTT) is a routine clotting assay that is widely used to globally screen for coagulation abnormalities. It is commonly admitted that a prolonged test result, may trigger the need for specific assays to be performed, particularly factor measurement. However, the sensitivity of aPTT reagents to deficiencies of clotting factors varies. Methods: We evaluated, according to the recommendation of the CLSI H47-A2 guideline, the responsiveness to single factor levels of five aPTT reagents by using factor-deficient plasmas spiked with a calibration plasma to produce individual factor activities ranging from <1 to similar to 100 Unit (U)/dL. Test results were expressed as the sample-to-control ratio, the latter was defined as the clotting time obtained in the calibration plasma containing similar to 100 U/dL factor activity. The factor activity producing a prolongation of aPTT above the upper limit of its specific normal range (in ratio) was assigned as the factor responsiveness in U/dL to that reagent. Results: Responsiveness ranged from 34 to 47 U/dL to FVIII: C, from 18 to 57 U/dL to FIX, from 38 to 52 U/dL to FXI, from 29 to 50 U/dL to FXII, from 40 and 59 U/dL to FV, from 7.5 to 49 U/dL to FX, and from 9.1 to 10.5 U/dL to FII. Conclusions: These results suggest that the sensitivity of the tested aPTT reagents to single factor deficiency is highly variable. Moreover, for one given aPTT reagent, its sensitivity was very different depending on the deficient factor. This must be considered when analyzing clinical materials.
引用
收藏
页码:389 / 396
页数:8
相关论文
共 41 条
  • [11] CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
  • [12] Screening coagulation testing using the APTT: Which reagent to choose?
    Dembitzer, Francine R.
    Suarez, Yvelisse
    Aledort, Louis M.
    Peerschke, Ellinor I. B.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (09) : 726 - 727
  • [13] Recommendations for Appropriate Activated Partial Thromboplastin Time Reagent Selection and Utilization
    Fritsma, George A.
    Dembitzer, Francine R.
    Randhawa, Ankush
    Marques, Marisa B.
    Van Cott, Elizabeth M.
    Adcock-Funk, Dorothy
    Peerschke, Ellinor I.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (06) : 904 - 908
  • [14] Parenteral Anticoagulants Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    Garcia, David A.
    Baglin, Trevor P.
    Weitz, Jeffrey I.
    Samama, Meyer Michel
    [J]. CHEST, 2012, 141 (02) : E24S - E43S
  • [15] HATHAWAY WE, 1979, AM J CLIN PATHOL, V71, P22
  • [16] THE CAUSE OF TURBIDITY IN LYOPHILIZED PLASMAS AND ITS EFFECTS ON COAGULATION TESTS
    HIRST, CF
    POLLER, L
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (08) : 701 - 703
  • [17] HOFFMANN JJML, 1978, THROMB HAEMOSTASIS, V39, P640
  • [18] JOHNSTONE IB, 1984, CAN J COMP MED, V48, P198
  • [19] To bleed or not to bleed? is that the question for the PTT?
    Kitchens, CS
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (12) : 2607 - 2611
  • [20] LANGDELL RD, 1953, J LAB CLIN MED, V41, P637